We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Insights Into Axon (AXON) Q4: Wall Street Projections for Key Metrics
Read MoreHide Full Article
In its upcoming report, Axon Enterprise (AXON - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $1.67 per share, reflecting a decline of 19.7% compared to the same period last year. Revenues are forecasted to be $753.65 million, representing a year-over-year increase of 31%.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
With that in mind, let's delve into the average projections of some Axon metrics that are commonly tracked and projected by analysts on Wall Street.
The collective assessment of analysts points to an estimated 'Net Sales- Products' of $417.23 million. The estimate indicates a year-over-year change of +26.4%.
According to the collective judgment of analysts, 'Net Sales- Services' should come in at $336.32 million. The estimate indicates a year-over-year change of +37.3%.
Analysts' assessment points toward 'Annual recurring revenue' reaching $1368.50 . The estimate is in contrast to the year-ago figure of $1001.00 .
Over the past month, Axon shares have recorded returns of -29.5% versus the Zacks S&P 500 composite's -0.8% change. Based on its Zacks Rank #3 (Hold), AXON will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Insights Into Axon (AXON) Q4: Wall Street Projections for Key Metrics
In its upcoming report, Axon Enterprise (AXON - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $1.67 per share, reflecting a decline of 19.7% compared to the same period last year. Revenues are forecasted to be $753.65 million, representing a year-over-year increase of 31%.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
With that in mind, let's delve into the average projections of some Axon metrics that are commonly tracked and projected by analysts on Wall Street.
The collective assessment of analysts points to an estimated 'Net Sales- Products' of $417.23 million. The estimate indicates a year-over-year change of +26.4%.
According to the collective judgment of analysts, 'Net Sales- Services' should come in at $336.32 million. The estimate indicates a year-over-year change of +37.3%.
Analysts' assessment points toward 'Annual recurring revenue' reaching $1368.50 . The estimate is in contrast to the year-ago figure of $1001.00 .
View all Key Company Metrics for Axon here>>>Over the past month, Axon shares have recorded returns of -29.5% versus the Zacks S&P 500 composite's -0.8% change. Based on its Zacks Rank #3 (Hold), AXON will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .